Article Versions Notes

Rettl R, Dachs T-M, Duca F, Binder C, Dusik F, Seirer B, Schönauer J, Kronberger C, Camuz Ligios L, Hengstenberg C, et al. What Type of Patients Did PARAGON-HF Select? Insights from a Real-World Prospective Cohort of Patients with Heart Failure and Preserved Ejection Fraction. Journal of Clinical Medicine. 2020; 9(11):3669. https://doi.org/10.3390/jcm9113669

Rettl, René, Theresa-Marie Dachs, Franz Duca, Christina Binder, Fabian Dusik, Benjamin Seirer, Johannes Schönauer, Christina Kronberger, Luciana Camuz Ligios, Christian Hengstenberg, and et al. 2020. "What Type of Patients Did PARAGON-HF Select? Insights from a Real-World Prospective Cohort of Patients with Heart Failure and Preserved Ejection Fraction" Journal of Clinical Medicine 9, no. 11: 3669. https://doi.org/10.3390/jcm9113669

Rettl, R., Dachs, T.-M., Duca, F., Binder, C., Dusik, F., Seirer, B., Schönauer, J., Kronberger, C., Camuz Ligios, L., Hengstenberg, C., Derkits, N., Kastner, J., Badr Eslam, R., & Bonderman, D. (2020). What Type of Patients Did PARAGON-HF Select? Insights from a Real-World Prospective Cohort of Patients with Heart Failure and Preserved Ejection Fraction. Journal of Clinical Medicine, 9(11), 3669. https://doi.org/10.3390/jcm9113669